JCR Pharmaceuticals Co Ltd
OTC:JCRRF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Yellow Pages Ltd
TSX:Y
|
CA |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its 3-Year Average (10.5), the stock would be worth $-1.85 (137% downside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -28.3 | $5 |
0%
|
| 3-Year Average | 10.5 | $-1.85 |
-137%
|
| 5-Year Average | 13.5 | $-2.38 |
-148%
|
| Industry Average | 10.6 | $-1.87 |
-137%
|
| Country Average | 8.7 | $-1.53 |
-131%
|
Forward EV/EBITDA
Today’s price vs future ebitda
| Today's Enterprise Value | EBITDA | Forward EV/EBITDA | ||
|---|---|---|---|---|
|
$82.2B
|
/ |
Jan 2026
¥-2.5B
|
= |
|
|
$82.2B
|
/ |
Mar 2026
¥4.7B
|
= |
|
|
$82.2B
|
/ |
Mar 2027
¥5.7B
|
= |
|
|
$82.2B
|
/ |
Mar 2028
¥6.1B
|
= |
|
Forward EV/EBITDA shows whether today’s EV/EBITDA still looks high or low once future ebitda are taken into account.
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| JP |
J
|
JCR Pharmaceuticals Co Ltd
OTC:JCRRF
|
70.5B USD | -28.3 | -28.9 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
853.2B USD | 28.4 | 42 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
544.6B USD | 16.5 | 25.6 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 11.6 | 19.6 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
225.4B GBP | 16.2 | 29.2 | |
| CH |
|
Novartis AG
SIX:NOVN
|
222.8B CHF | 12.4 | 20 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
278.5B USD | 9.5 | 15.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 386.8 | -83.6 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 8 | 10.8 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
155.3B USD | 7.6 | 19.6 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
119.6B USD | 7.1 | 16.8 |
Market Distribution
| Min | 0.1 |
| 30th Percentile | 6.7 |
| Median | 8.7 |
| 70th Percentile | 12.2 |
| Max | 214 699 781.2 |
Other Multiples
JCR Pharmaceuticals Co Ltd
Glance View
JCR Pharmaceuticals Co., Ltd. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Ashiya-Shi, Hyogo-Ken and currently employs 732 full-time employees. The firm operates in two segments. The Pharmaceutical segment engages in the research, production, purchase and sale of medical drugs and pharmaceutical raw materials. The Medical and Research Equipment segment engages in the purchase and sale of the medical and research equipment.
